In a study involving 1,785 people, researchers identified a test that can help diagnose early-stage pancreatic cancer.
Thunderous applause at this year’s American Society for Clinical Oncology (ASCO) meeting in May — hardly the typical reaction ...
Learn about a new blood test that could allow physicians to detect pancreatic cancer in its earliest stages by combining ...
Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer, is also showing promise in the ...
Researchers found that blocking IL1RAP could disrupt a powerful inflammatory network that helps pancreatic cancer survive ...
Campus Insights Media on MSN
Pancreatic cancer treatment approved by FDA
On Aug. 26, the U.S. Food and Drug Administration approved a drug called Rasonque (daraxonrasib) as a new treatment opti ...
The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.
On learning she had stage 4 pancreatic cancer that had spread to her liver, Roxane Isal's first thoughts were for her ...
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer.
The National Cancer Institute estimates that about 67,000 people will be diagnosed with pancreatic cancer in 2026.
ClearNote Health will present new data for its Avantect® Pancreatic Cancer Test and its Virtuoso® platform at the AACR Conference on Pancreatic Cancer ...
Researchers at City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results